Second Quarter HighlightsFirst-half of fiscal year bookings reach a record of $533M exceeding FY2019 full year bookingsRecord quarterly GAAP revenue […]
STAMFORD, Conn., May 07, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing […]